With the strength and global reach of the Acorn Group behind it, TONIK emerges as a design-driven, future-focused leader ...

Rough Clothing, has officially opened its flagship store at Colombo City Centre (CCC), marking a significant milestone after 27 successful years in the wholesale fashion industry and three years of ...

Jaipur: Students preparing for Biology board exam for Class 12 must prioritise topics according to the difficulty level and ...

Woody Allen wanted to achieve immortality by not dying rather than through his work. Recently, China's General Secretary Xi ...

JetBlue is finally set to introduce first class on its domestic routes after teasing the possibility years ago. Dubbed “Mini Mint” or “Junior Mint,” the first-class product will feature a ...

I never thought I would say this in the year 2025, but here it is: the United States is working on a brand-new battleship, the likes of which the seas of the world have not seen in countless decades.

JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today ...

Undertale and Deltarune creator Toby Fox previously said he doesn't think the latter game's Chapter 5 "will be released in the first half of 2026" – and that's looking very possible now, as he reveals ...

Months after warning investors that the clock was ticking, iRobot has officially pulled the Chapter 11 lever. The company behind the Roomba robot vacuum cleaner has entered a pre-packaged bankruptcy ...

The University of Virginia has extended admission offers to the first members of the Class of 2030. Friday afternoon, 1,225 applicants received offers of admission, including 766 Virginians. UVA has ...

Premium customers may be driving travel spending these days, but United’s David Kinzelman said airlines can’t forget about economy travelers. United Airlines is no exception, with plans to roll out ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...